Magellan™ Robotic System

The Magellan Robotic System is an advanced technology that affords your physician precision and control during the most delicate aspects of your procedure. It is for women and men seeking a less invasive option to treat the following:

  • Vascular Disease
  • Uterine Fibroids
  • Prostate Enlargement
  • Liver Cancer
  • Your physician uses the Magellan system to navigate through your blood vessels with robotic catheters. Unlike traditional catheters, robotic catheters do not have a pre-set shape. They can be re-shaped and steered during the procedure, offering your physician enhanced precision and control when navigating through the often narrow and winding pathways inside your blood vessels. Magellan is designed to help physicians reliably reach and treat vascular blockages and other conditions via the less invasive, endovascular approach.

  • Peripheral Vascular Disease: Peripheral Vascular Disease refers to diseases of the blood vessels outside of the brain and heart. It is estimated to affect nearly 8 million people in the U.S., including approximately 15% of people older than age 60. This can include treatment of conditions such as Abdominal Aortic Aneurysms, Lower Extremity Peripheral Artery Disease (PAD), Renal and Mesenteric Disease, and diseases of the Veins, among others. Learn more about Vascular Procedures with the Magellan Robotic System.
  • Uterine Fibroids: Uterine fibroids are non-cancerous tumors in or around the uterus, and are the most common benign tumors in women. Between 20 and 40% of women over the age of 20 will develop a symptomatic uterine fibroid before reaching menopause. Learn more about Uterine Fibroid Embolization with the Magellan Robotic System.
  • Enlarged Prostate, or BPH: Benign Prostatic Hyperplasia (BPH) or enlargement of the prostate, is a common condition that affects over 50% of men aged 50 and as high as 80% of men aged 80 or older. The continued enlargement of the prostate gland can lead to difficulties associated with the bladder and urination. Learn more about Prostatic Artery Embolization (PAE) with the Magellan Robotic System.
  • Liver Cancer: Transarterial Chemoembolization (TACE) is a minimally-invasive procedure involving catheter-based delivery of small embolic materials into selected, small arteries to cut off the blood supply feeding a tumor in the liver. Learn more about TACE procedures with the Magellan Robotic System.
  • To learn more about the Magellan™ Robotic System for gynecological surgery, click here .

    Would you like to get more information about our robotic services at The Hospitals of Providence? Call 915-577-8467 (THOP) to find a physician in your area or use the links below to learn more.